TABLE 1.

Treatment regimen following diagnosis of lymphoma

Patient #	Gender	Age at first draw (years)	Regimens
1001	M	56	B
1002	M	60	B1
1003	F	56	A2
1004	F	72	A1
1005	M	61	A3
1006	M	49	A1
1007	F	66	A4
1008	F	38	C
1009	M	58	A5
1010	M	71	A1

A, CHOP; A1, CHOP-R (rituxan) × 6; A2, CHOP × 7; R × 8; A3, CHOP × 6; Bexxar (radioimmunotherapy) × 1; A4, CHOP-R × 4; CVP-R × 1; GaRD (× 5); A5, CHOP-R × 4; Etoposide; Stem Cell Transplant; B, HyperCVAD; B1, HyperCVAD; Rituximab; C, ABVD × 10. Regimen Key: CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone); HyperCVAD (cyclophosphamide, cytarabine, doxorubicin, etoposide, methotrexate, vincristine). CVP-R (cyclophosphamide, vincristine, prednisone, rituxan); GaRD (gallium, rituxan, dexamethasone). ABVD (adriamycin, bleomycin, decarbazine, vinblastine). Drugs targeting Topoisomerase II shown in bold.